These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7834482)

  • 21. Use of contrast material for spiral CT of the abdomen: comparison of hepatic enhancement and vascular attenuation for three different contrast media at two different delay times.
    Herts BR; Paushter DM; Einstein DM; Zepp R; Friedman RA; Obuchowski N
    AJR Am J Roentgenol; 1995 Feb; 164(2):327-31. PubMed ID: 7839963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective evaluation of the contrast, radiation dose and image quality of contrast-enhanced CT scans of paediatric abdomens using a low-concentration iodinated contrast agent and low tube voltage combined with 70% ASIR algorithm.
    Wang X; Zhong Y; Hu L; Xue L; Shi M; Qiu H; Li J
    Int J Clin Pract; 2016 Sep; 70 Suppl 9B():B16-21. PubMed ID: 27577509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of a low-osmolar contrast medium, iopamidol, and an iso-osmolar contrast medium, iodixanol, in MDCT coronary angiography.
    Ozbulbul NI; Yurdakul M; Tola M
    Coron Artery Dis; 2010 Nov; 21(7):414-9. PubMed ID: 20671550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of viscosity and iodine concentration of nonionic radiographic contrast media on coronary arteriography in patients.
    Kern MJ; Roth RA; Aguirre FV; Beauman G; Vogel R
    Am Heart J; 1992 Jan; 123(1):160-5. PubMed ID: 1729820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An observational study to evaluate the efficiency and safety of ioversol pre-filled syringes compared with ioversol bottles in contrast-enhanced examinations.
    Vogl TJ; Wessling J; Buerke B
    Acta Radiol; 2012 Oct; 53(8):914-20. PubMed ID: 22983259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic Hypotension Following Intravenous Administration of Nonionic Contrast Medium During Computed Tomography: Iopromide Versus Iodixanol.
    Widmann G; Bale R; Ulmer H; Putzer D; Schullian P; Wiedermann FJ; Lederer W
    Anesth Analg; 2018 Mar; 126(3):769-775. PubMed ID: 28806208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective ECG-triggering cardiac CT for infants with complex congenital heart disease using low-dose contrast medium, low tube voltage, and adaptive statistical iterative reconstruction.
    Wang SY; Gao W; Zhong YM; Sun AM; Wang Q; Hu LW; Qiu HS; Li JY
    Clin Radiol; 2017 Jun; 72(6):502-507. PubMed ID: 28267987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the low-osmolality contrast medium ioversol (Optiray) on renal function in a geriatric population.
    Louvel JP; Primard E; Henry J; Houlette C; Weinstein A; Janvresse A
    Acta Radiol; 1996 Nov; 37(6):950-3. PubMed ID: 8995472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ioversol 300 and iopamidol 300 in "whole body" computed tomography. A double-blind clinical trial].
    Chagnaud C; Moulin G; Delannoy L; Gaubert JY; Haddad D; Bartoli JM; Kasbarian M
    Ann Radiol (Paris); 1992; 35(4 Pt 2):276-9. PubMed ID: 1296491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of efficacy and tolerability of ioversol in intravenous urography. A comparative double-blind study versus iopamidol].
    Joffre F; Rousseau H; Aziza R
    Ann Radiol (Paris); 1992; 35(4 Pt 2):288-92. PubMed ID: 1296494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical profile of ioversol. A metaanalysis of 57 randomized, double-blind clinical trials.
    Floriani I; Ciceri M; Torri V; Tinazzi A; Jahn H; Noseda A
    Invest Radiol; 1996 Aug; 31(8):479-91. PubMed ID: 8854194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of varying rates of low-osmolarity contrast media injection for hepatic CT: correlation with indocyanine green transit time.
    Harmon BH; Berland LL; Lee JY
    Radiology; 1992 Aug; 184(2):379-82. PubMed ID: 1620831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU.
    Ng CS; Shaw AD; Bell CS; Samuels JA
    AJR Am J Roentgenol; 2010 Aug; 195(2):414-22. PubMed ID: 20651198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind comparative study on the contrast quality, tolerance and safety of ioversol 300 versus iohexol 300 in central venous angiography (C.V. DSA).
    Rieser R; Beinborn W; Ney N
    Ann Radiol (Paris); 1992; 35(4 Pt 2):311-4. PubMed ID: 1296499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A prospective study about an imaging quality of low dosage of contrast media with single-detector CT].
    Saku M; Murakami J; Nakamura Y; Yamaguchi T; Komori T; Kimura M; Oguri S; Noguchi T; Iida T; Kamitani T
    Fukuoka Igaku Zasshi; 2004 May; 95(5):118-23. PubMed ID: 15285057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of coronary computed tomography angiography image quality with high- and low-concentration contrast agents (CONCENTRATE): study protocol for a randomized controlled trial.
    Im DJ; Kim YH; Choo KS; Kang JW; Jung JI; Won Y; Kim HR; Chung MH; Han K; Choi BW
    Trials; 2016 Jul; 17(1):315. PubMed ID: 27418333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of diagnostic efficacy and clinical tolerability of ioversol in "whole body" computed tomography in children. A non comparative phase III trial].
    Panuel M; Devred P; Faure F; Bourlière-Najean B; Ternier F; Le Bail C
    Ann Radiol (Paris); 1992; 35(4 Pt 2):280-3. PubMed ID: 1296492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re-evaluation of optimal dose of contrast medium for vascular enhancement in CT of the head and neck.
    Yoon DY; Chang KH; Han MH; Kim HD; Kim SH; Kim TK; Han MC
    Neuroradiology; 1997 Jan; 39(1):30-4. PubMed ID: 9121645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
    Barrett BJ; Katzberg RW; Thomsen HS; Chen N; Sahani D; Soulez G; Heiken JP; Lepanto L; Ni ZH; Ni ZH; Nelson R
    Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [No detectable nephrotoxic side effect using a dimer, non-ionic contrast media in cerebral perfusion computed tomography in case of suspected brain ischemia].
    Petrik M; Weigel C; Kirsch M; Hosten N
    Rofo; 2005 Sep; 177(9):1242-9. PubMed ID: 16123870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.